GlassScriptPhysician profile
Gregory C Gore
NPI 1477542504
$1,081.79
in general payments reported to CMS, 2019-2025
14 companies · $152 in 2025
The $152 reported for 2025 was less than what a typical Adult Health (Nurse Practitioner) provider received nationally (typical 2025 total: $182).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $419 · 2022: $121 · 2023: $238 · 2024: $152 · 2025: $152.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $541.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $541.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Collegium Pharmaceutical, INC. | $451.01 | 2021-2025 | Xtampza |
| Biodelivery Sciences International, INC. | $165.31 | 2021 | |
| Scilex Pharmaceuticals INC. | $76.05 | 2021-2022 | |
| Almatica Pharma LLC | $71.66 | 2021-2023 | Gralise |
| Saluda Medical Americas, INC. | $71.49 | 2023 | Evoke Scs |
| Vertex Pharmaceuticals Incorporated | $59.47 | 2024-2025 | |
| Abbvie INC. | $52.41 | 2023-2025 | |
| Protega Pharmaceutials INC | $28.53 | 2023 | Roxybond |
| Pacira Pharmaceuticals Incorporated | $22.34 | 2024 | Iovera, Zilretta, Exparel |
| Averitas Pharma INC. | $21.16 | 2023 | Qutenza |
| Medtronic, INC. | $17.10 | 2021 | |
| Boston Scientific Corporation | $16.91 | 2025 | Spectra Wavewriter |
| Tersera Therapeutics LLC | $15.11 | 2025 | Prialt |
| Redhill Biopharma INC. | $13.24 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Gore listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.